Drug Screening Market

The Rising Prevalence of Drug Abuse and Strict Government Regulations are Transforming the Market Growth

Drug Screening Market by Sample Type, Product and Service, End User & Region | Forecast 2023 to 2033

Drug Screening Market Outlook

The drug screening market is likely to expand its roots at a strong CAGR of 16.1% during the forecast period. The market holds a share of US$ 7.3 billion in 2023 while it is anticipated to cross a value of US$ 32.4 billion by 2033.

The research report on the drug screening market explains that more and more people indulging in drug consumption of different types along with the increasing number of rehab centers. Furthermore, the new government policies limit the use of drugs and drug trafficking are pushing the sales of drug screening solutions. Drug addicts promoting violence and drug abuse are pushing authorities to control the dissemination of drugs. The misuse and black marketing of prescribed drugs are fueling the demand for drug screening solutions. Furthermore, the development of drug screening products with higher efficiency and effectiveness gains traction for drug screening solutions. The higher penetration of recreational drugs among young people is fueling the demand for advanced drug screening solutions. Higher limitations on occupational drugs in non-Islamic countries are fueling the demand for drug screening solutions.

The drug screening market outlook states that the upcoming drug testing technology that is smart, efficient, and fast is likely to transform the market. Furthermore, the workspace discipline and extended drug screening prospects are fueling the demand for drug screening products.

Attributes	Details
Drug Screening Market CAGR (2023 to 2033)	16.1%
Drug Screening Market Size (2023)	US$ 7.3 billion
Drug Screening Market Size (2033)	US$ 32.4 billion

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

How is the Future Outlook (2023 to 2033) for Drug Screening Market in Comparison to the Historical Pattern (2017 to 2022)

Short-term Growth: From 2017 to 2022, the global Drug Screening market registered a comparatively higher CAGR of 19.3%. The rise in regulatory approvals for the drug screening laboratory services market is ascribed to increased drug and alcohol usage and the implementation of rigorous legislation demanding alcohol and drug test. Bans on alcohol use in Islamic nations and limitations on an occupational drug tests in selected countries, on the other hand, may limit the market’s growth to some extent.

Mid-term Growth: Teenage illicit alcohol usage, rising road accidents owing to a drug overdose while driving, and prescription medication abuse are predicted to fuel market revenue growth. The growth between 2022 and 2028 is likely to be steady.

Long-term Growth: Covid-19 pandemic resulted in a worldwide restriction on the movement of people and led to the isolation of individuals in their own homes. This is the primary reason for the drop in demand for drug screening services as most of the workplaces were shut down, and healthcare resources were diverted to take care of covid-19 patients. However, apart from these factors limiting the growth, the market still thrives at a strong CAGR of 16.1% between 2023 and 2033.

What are the Drivers, Restraints, Opportunities, & Threats in the Drug Screening Market?

The development of improved screening technology and growing awareness of the benefits of alcohol or drug screening are creating business opportunities.

Drug misuse and alcohol usage are on the rise all around the world. According to the World Drug Report 2021, 275 million persons aged 15–64, or one out of every 18 people in that age group, took drugs at least once in the preceding year (range: 175 million to 374 million).

Drug use problems were expected to affect 36.3 million individuals worldwide, accounting for over 13% of the global population. Drug use killed about half a million individuals in the same year, and drug use disorders resulted in the loss of 18 million years of a healthy life, primarily owing to opioids.

Similar increases in alcohol intake have been seen, with the resultant rise in the prevalence of impaired driving. Development of drug screening products and services on the road, boosting the total market growth.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Drivers are Limiting the Drug Screening Adoption?

Alcohol and drug tests in the workplace are considered a breach of employee privacy in certain nations, including Canada, Colombia, Argentina, Chile, and South Africa. In France, for example, pre-employment saliva drug testing is only done when doctors prescribe it.

Workplace alcohol and drug tests are illegal in Poland and the Czech Republic. In Canada, Eastern Canadian case laws allow alcohol and immunoassay drug tests only where occupational activities are fundamentally risky or when alcohol and drug testing is confined to a few specific circumstances.

What are the Opportunities for the Drug Screening Market?

Disruptions in the global supply chain, diminished demand, and client suspensions have all been experienced by companies in the drug screening sector. The test examines microscopic amounts of perspiration in the fingerprint to identify drugs and drug metabolites. This test might eventually replace urine, hair, and blood-based immunoassay drug test.

Although fingerprint-based swab drug test can help prevent the spread of COVID, it is non-invasive, portable, time-saving, and sanitary allows for social distancing, is user-friendly, and requires no unique sample collection or handling preparation.

This test is simple to administer whenever and wherever needed, making it ideal for workplace drug testing. To identify drugs and drug metabolites, a home drug test examines microscopic amounts of perspiration in the fingerprint. Workplaces, criminal justice, police enforcement, and drug recovery programs employ this test, which are offering opportunities to the market players.

Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Sign-Up

Comparative View of the Drug Screening Market

Drug Screening Market:

Attributes	Drug Screening Market
CAGR (2023 to 2033)	16.1%
Market Value (2033)	US$ 32.4 billion
Growth Factor	The increased drug consumption along with the additional ruckus created is likely to fuel the demand for drug screening products.
Opportunity	Services like consultation, onsite testing, offsite testing, and fit-to-work program are creating opportunities for the market.
Key Trends	The government programs to limit drug use are shaping the growth trends for the market.

Drug Testing Market:

Attributes	Drug Testing Market
CAGR (2023 to 2033)	4.7%
Market Value (2033)	US$ 14.72 billion
Growth Factor	The increased alcohol consumption among adolescents and the elderly is likely to fuel the demand for drug testing kits.
Opportunity	The advent of corporate and workspace-based drug-controlling steps is likely to create opportunities for the drug-testing market
Key Trends	Ban on alcohol and drug consumption during work hours at government organizations is shaping the trends for the market.

Alcohol Tester Market:

Attributes	Alcohol Tester Market
CAGR (2023 to 2033)	6.9%
Market Value (2033)	US$ 23.24 million
Growth Factor	Higher cases of drunk-driving accidents and alcohol abuse are pushing organizations and governments to adopt alcohol testers.
Opportunity	The advent of portable oral fluid testing along with stringent policies around alcohol consumption are creating opportunities for the alcohol tester market.
Key Trends	Breathalyzer alcohol and drug testing equipment are creating growth trends in the market.

Drug Screening Market Country-wise Insights

Region	Absolute Market Growth
Chinese	US$ 8.8 billion
United Kingdom	US$ 1.0 billion
China	US$ 1.8 billion
Japan	US$ 1.4 billion
South Korea	US$ 837.2 million

Which Region leads the Market in terms of Market Share and CAGR?

The Higher Misuse of Prescribed Drugs along with the Stringent Government Policies fuels the Regional Growth

United States Market CAGR (2023 to 2033)	15.8%
United States Market Absolute Doller Growth (US$ Mn/Bn)	US$ 8.8 billion

According to the FMI market survey, the United States market thrives at a CAGR of 15.8% between 2023 and 2033 while it is expected to reach a value of US$ 11.5 billion by 2033. As there has been an increase in the consumption of illicit drugs by citizens of North American countries and the government increasingly investing in curbing drug abuse by establishing a drug screening laboratory services market, the region is expected to experience considerable growth in the years ahead. These factors make the United States the leading market in terms of market share and CAGR.

The growing burden of drunk and driving cases is also becoming a significant factor in law enforcement agencies growing demand for drug screening. Additionally, most of the primary critical players present in the North American drug screening market and adjoining areas have always favored the colossal market volume.

What makes China a Significance Drug Screening Market?

Increasing Cases of Drug Trafficking and Stringent Workspace Drug Norms flourishes the Sales of Drug Screening Solutions

Region	Attributes
Chinese Market CAGR (2023 to 2033)	15.4%
Chinese Market Absolute Doller Growth (US$ Mn/Bn)	US$ 1.8 billion

Chinese drug screening market future trends appear optimistic, with opportunities in the workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories. These factors make it the leading market in terms of market share and CAGR.

Fingerprint-based drug testing is a new concept that has gained traction and is one of the emerging trends in the Chinese drug screening market as an impact of COVID-19 on the overall drug screening market. Due to the risk of spreading the infection, the coronavirus has made it challenging to conduct drug testing in hospitals, labs, and other facilities. However, the Chinese market is still expected to hold US$ 2.3 billion in 2033 while thriving at a CAGR of 15.4% by 2033.

Category-wise Insights

Segment	Top Product and Service
Top Sub-segment	Rapid Testing Devices
CAGR (2017 to 2022)	19.1%
CAGR (2023 to 2033)	15.8%
Segment	Top End User
Top Sub-segment	Drug Testing Laboratories
CAGR (2017 to 2022)	18.6%
CAGR (2023 to 2033)	15.4%

Faster, Efficient, and Effective Results make Rapid Testing Devices the Top Product and Service Segment

The product and services for the drug screening laboratory services market are categorized into drug screening products, analytical instruments, rapid testing devices, consumables, and drug screening services. Analytical Instruments are primarily breathalyzers, immunoassay analyzers, and chromatography instruments. Rapid testing devices have started gaining importance for drug monitoring programs and are predicted to overtake the global drug screening market in the coming years. This segment is further classified according to devices such as urine testing devices and oral fluid testing devices. The segment is expected to thrive at a CAGR of 15.8% by 2033.

Organizations and Government offices lacking Testing Equipment fuels the Traction for the Drug Testing Laboratories Segment

Based on end-user type, drug testing laboratories are the top segment that thrives at a CAGR of 15.4% between 2023 and 2033. This is due to the lack of drug testing and screening equipment in private and government organizations. Despite the development of innovative drug screening methods, drug testing laboratories and hospitals will remain the significant consumers of products in the drug screening market. The segment thrived at a higher CAGR of 18.6% between 2017 and 2022.

Competition Scenario

Market players rely on the use of innovative technologies to derive efficiency in the drug screening kits and devices and get a hold of a better position in the drug screening market. In addition to this, the focus has also been on inorganic growth to get the benefit of collaboration and mutual growth. The key players in the market include Labcorp, Quest Diagnostics, Abbott Laboratories, and Orasure Technologies.

Recent Market Developments

The Omega Hair 17-panel drug test can detect multiple psychoactive substances, particularly benzodiazepines. It was developed by Omega laboratories and was introduced in 2018.
Detection of any ingestion of Marijuana, CBD, and nicotine drugs by a vaping panel test was introduced by Psychemedics.
Two US companies named Infirmary Health and LabCorp have agreed to offer laboratory testing services in the countries of the Eastern Gulf Coast.

Major Contributors of the Drug Screening Market

Laboratory Corporation of America Holdings,
Hoffmann -La Roche Ltd
BioMerieux SA
Express Diagnostics Int’l, Inc.
Bio-Rad Laboratories Inc.
Biomedical Diagnostics
Danaher
Synergy Health plc.
Agilent Technologies
Shimadzu Medical Pvt. Ltd.
Alere Inc.
Premier Biotech, Inc.
Psychemedics Corporation
Siemens Healthineers Private Limited
American Bio Medica Corporation
Sciteck, Inc.
ACM Global Laboratories.
CareHealth America
Clinical Reference Laboratory, Inc.

Key Segments

By Sample Type:

Urine samples
Breath Samples
Oral Fluid Samples
Hair Samples
Other Samples

By Product and Service:

Drug screening
Analytical Instruments
Rapid Testing Devices
Consumables
Drug Screening Service

By End User:

Drug Testing Laboratories
Criminal Justice and Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
Schools and Colleges
Workplaces

By Region:

North America
Latin America
Europe
Asia Pacific (APAC)
Middle East & Africa (MEA)

Frequently Asked Questions

What was the global Drug Screening Market size reported by FMI for 2022?

The drug screening market held a value of US$ 6.15 billion in 2022.

What is the Drug Screening Market estimated to reach in 2023?

The market holds a value of US$ 7.3 billion in 2023.

What is the Drug Screening Market valuation expected for 2033?

The drug screening market is anticipated to hold a share of US$ 32.4 billion by 2033.

What value CAGR did the Drug Screening Market exhibit over the last 4 years?

The drug screening market expanded at a 19.3% CAGR in the last four years, from 2017 to 2022.

What is the projected CAGR for the Drug Screening Market from 2023 to 2033?

The drug screening market is expected to have a CAGR of 16.1% by 2033.

Which Product and Service type is predicted to expand rapidly between 2023 and 2033?

Rapid testing devices are expected to lead the product and service type category with a CAGR of 15.8% between 2023 and 2033.

Which End User Type is predicted to expand rapidly between 2023 and 2033?

The drug testing laboratories segment is anticipated to top the end-user type tally with a CAGR of 4.9% during the forecast period.

Table of Content

1. Executive Summary | Drug Screening Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Sample Type, 2017 to 2022

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033

5.3.1. Urine samples

5.3.2. Breath Samples

5.3.3. Oral Fluid Samples

5.3.4. Hair Samples

5.3.5. Other Samples

5.4. Y-o-Y Growth Trend Analysis By Sample Type, 2017 to 2022

5.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product and Service

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Million) Analysis By Product and Service, 2017 to 2022

6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product and Service, 2023 to 2033

6.3.1. Drug Screening

6.3.2. Analytical Instruments

6.3.3. Rapid Testing Devices

6.3.4. Consumables

6.3.5. Service

6.4. Y-o-Y Growth Trend Analysis By Product and Service, 2017 to 2022

6.5. Absolute $ Opportunity Analysis By Product and Service, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2017 to 2022

7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033

7.3.1. Drug Testing Laboratories

7.3.2. Criminal Justice and Law Enforcement Agencies

7.3.3. Hospitals

7.3.4. Drug Treatment Centers

7.3.5. Individual Users

7.3.6. Pain Management Centers

7.3.7. Schools and Colleges

7.3.8. Workplaces

7.4. Y-o-Y Growth Trend Analysis By End User , 2017 to 2022

7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. Asia Pacific

8.3.5. Middle East and Africa

8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

9.2.1. By Country

9.2.1.1. The USA

9.2.1.2. Canada

9.2.2. By Sample Type

9.2.3. By Product and Service

9.2.4. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Sample Type

9.3.3. By Product and Service

9.3.4. By End User

9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

10.2.1. By Country

10.2.1.1. Brazil

10.2.1.2. Mexico

10.2.1.3. Rest of Latin America

10.2.2. By Sample Type

10.2.3. By Product and Service

10.2.4. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Sample Type

10.3.3. By Product and Service

10.3.4. By End User

10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. United Kingdom (UK)

11.2.1.3. France

11.2.1.4. Spain

11.2.1.5. Italy

11.2.1.6. Rest of Europe

11.2.2. By Sample Type

11.2.3. By Product and Service

11.2.4. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Sample Type

11.3.3. By Product and Service

11.3.4. By End User

11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

12.2.1. By Country

12.2.1.1. China

12.2.1.2. Japan

12.2.1.3. South Korea

12.2.1.4. Thailand

12.2.1.5. Singapore

12.2.1.6. Australia

12.2.1.7. Rest of Asia Pacific

12.2.2. By Sample Type

12.2.3. By Product and Service

12.2.4. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Sample Type

12.3.3. By Product and Service

12.3.4. By End User

12.4. Key Takeaways

13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

13.2.1. By Country

13.2.1.1. GCC Countries

13.2.1.2. South Africa

13.2.1.3. Israel

13.2.1.4. Rest of Middle East and Africa

13.2.2. By Sample Type

13.2.3. By Product and Service

13.2.4. By End User

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Sample Type

13.3.3. By Product and Service

13.3.4. By End User

13.4. Key Takeaways

14. Key Countries Market Analysis

14.1. USA

14.1.1. Pricing Analysis

14.1.2. Market Share Analysis, 2022

14.1.2.1. By Sample Type

14.1.2.2. By Product and Service

14.1.2.3. By End User

14.2. Canada

14.2.1. Pricing Analysis

14.2.2. Market Share Analysis, 2022

14.2.2.1. By Sample Type

14.2.2.2. By Product and Service

14.2.2.3. By End User

14.3. Brazil

14.3.1. Pricing Analysis

14.3.2. Market Share Analysis, 2022

14.3.2.1. By Sample Type

14.3.2.2. By Product and Service

14.3.2.3. By End User

14.4. Mexico

14.4.1. Pricing Analysis

14.4.2. Market Share Analysis, 2022

14.4.2.1. By Sample Type

14.4.2.2. By Product and Service

14.4.2.3. By End User

14.5. Germany

14.5.1. Pricing Analysis

14.5.2. Market Share Analysis, 2022

14.5.2.1. By Sample Type

14.5.2.2. By Product and Service

14.5.2.3. By End User

14.6. UK

14.6.1. Pricing Analysis

14.6.2. Market Share Analysis, 2022

14.6.2.1. By Sample Type

14.6.2.2. By Product and Service

14.6.2.3. By End User

14.7. France

14.7.1. Pricing Analysis

14.7.2. Market Share Analysis, 2022

14.7.2.1. By Sample Type

14.7.2.2. By Product and Service

14.7.2.3. By End User

14.8. Spain

14.8.1. Pricing Analysis

14.8.2. Market Share Analysis, 2022

14.8.2.1. By Sample Type

14.8.2.2. By Product and Service

14.8.2.3. By End User

14.9. Italy

14.9.1. Pricing Analysis

14.9.2. Market Share Analysis, 2022

14.9.2.1. By Sample Type

14.9.2.2. By Product and Service

14.9.2.3. By End User

14.10. China

14.10.1. Pricing Analysis

14.10.2. Market Share Analysis, 2022

14.10.2.1. By Sample Type

14.10.2.2. By Product and Service

14.10.2.3. By End User

14.11. Japan

14.11.1. Pricing Analysis

14.11.2. Market Share Analysis, 2022

14.11.2.1. By Sample Type

14.11.2.2. By Product and Service

14.11.2.3. By End User

14.12. South Korea

14.12.1. Pricing Analysis

14.12.2. Market Share Analysis, 2022

14.12.2.1. By Sample Type

14.12.2.2. By Product and Service

14.12.2.3. By End User

14.13. Thailand

14.13.1. Pricing Analysis

14.13.2. Market Share Analysis, 2022

14.13.2.1. By Sample Type

14.13.2.2. By Product and Service

14.13.2.3. By End User

14.14. Singapore

14.14.1. Pricing Analysis

14.14.2. Market Share Analysis, 2022

14.14.2.1. By Sample Type

14.14.2.2. By Product and Service

14.14.2.3. By End User

14.15. Australia

14.15.1. Pricing Analysis

14.15.2. Market Share Analysis, 2022

14.15.2.1. By Sample Type

14.15.2.2. By Product and Service

14.15.2.3. By End User

14.16. GCC Countries

14.16.1. Pricing Analysis

14.16.2. Market Share Analysis, 2022

14.16.2.1. By Sample Type

14.16.2.2. By Product and Service

14.16.2.3. By End User

14.17. South Africa

14.17.1. Pricing Analysis

14.17.2. Market Share Analysis, 2022

14.17.2.1. By Sample Type

14.17.2.2. By Product and Service

14.17.2.3. By End User

14.18. Israel

14.18.1. Pricing Analysis

14.18.2. Market Share Analysis, 2022

14.18.2.1. By Sample Type

14.18.2.2. By Product and Service

14.18.2.3. By End User

15. Market Structure Analysis

15.1. Competition Dashboard

15.2. Competition Benchmarking

15.3. Market Share Analysis of Top Players

15.3.1. By Regional

15.3.2. By Sample Type

15.3.3. By Product and Service

15.3.4. By End User

16. Competition Analysis

16.1. Competition Deep Dive

16.1.1. Laboratory Corporation of America Holdings

16.1.1.1. Overview

16.1.1.2. Product Portfolio

16.1.1.3. Profitability by Market Segments

16.1.1.4. Sales Footprint

16.1.1.5. Strategy Overview

16.1.1.5.1. Marketing Strategy

16.1.2. Hoffmann -La Roche Ltd

16.1.2.1. Overview

16.1.2.2. Product Portfolio

16.1.2.3. Profitability by Market Segments

16.1.2.4. Sales Footprint

16.1.2.5. Strategy Overview

16.1.2.5.1. Marketing Strategy

16.1.3. BioMerieux SA

16.1.3.1. Overview

16.1.3.2. Product Portfolio

16.1.3.3. Profitability by Market Segments

16.1.3.4. Sales Footprint

16.1.3.5. Strategy Overview

16.1.3.5.1. Marketing Strategy

16.1.4. Express Diagnostics Int’l, Inc.

16.1.4.1. Overview

16.1.4.2. Product Portfolio

16.1.4.3. Profitability by Market Segments

16.1.4.4. Sales Footprint

16.1.4.5. Strategy Overview

16.1.4.5.1. Marketing Strategy

16.1.5. Bio-Rad Laboratories Inc.

16.1.5.1. Overview

16.1.5.2. Product Portfolio

16.1.5.3. Profitability by Market Segments

16.1.5.4. Sales Footprint

16.1.5.5. Strategy Overview

16.1.5.5.1. Marketing Strategy

16.1.6. Biomedical Diagnostics

16.1.6.1. Overview

16.1.6.2. Product Portfolio

16.1.6.3. Profitability by Market Segments

16.1.6.4. Sales Footprint

16.1.6.5. Strategy Overview

16.1.6.5.1. Marketing Strategy

16.1.7. Danaher

16.1.7.1. Overview

16.1.7.2. Product Portfolio

16.1.7.3. Profitability by Market Segments

16.1.7.4. Sales Footprint

16.1.7.5. Strategy Overview

16.1.7.5.1. Marketing Strategy

16.1.8. Synergy Health plc.

16.1.8.1. Overview

16.1.8.2. Product Portfolio

16.1.8.3. Profitability by Market Segments

16.1.8.4. Sales Footprint

16.1.8.5. Strategy Overview

16.1.8.5.1. Marketing Strategy

16.1.9. Agilent Technologies

16.1.9.1. Overview

16.1.9.2. Product Portfolio

16.1.9.3. Profitability by Market Segments

16.1.9.4. Sales Footprint

16.1.9.5. Strategy Overview

16.1.9.5.1. Marketing Strategy

16.1.10. Shimadzu Medical Pvt. Ltd.

16.1.10.1. Overview

16.1.10.2. Product Portfolio

16.1.10.3. Profitability by Market Segments

16.1.10.4. Sales Footprint

16.1.10.5. Strategy Overview

16.1.10.5.1. Marketing Strategy

16.1.11. Alere Inc.

16.1.11.1. Overview

16.1.11.2. Product Portfolio

16.1.11.3. Profitability by Market Segments

16.1.11.4. Sales Footprint

16.1.11.5. Strategy Overview

16.1.11.5.1. Marketing Strategy

16.1.12. Premier Biotech, Inc.

16.1.12.1. Overview

16.1.12.2. Product Portfolio

16.1.12.3. Profitability by Market Segments

16.1.12.4. Sales Footprint

16.1.12.5. Strategy Overview

16.1.12.5.1. Marketing Strategy

16.1.13. Psychemedics Corporation

16.1.13.1. Overview

16.1.13.2. Product Portfolio

16.1.13.3. Profitability by Market Segments

16.1.13.4. Sales Footprint

16.1.13.5. Strategy Overview

16.1.13.5.1. Marketing Strategy

16.1.14. Siemens Healthineers Private Limited

16.1.14.1. Overview

16.1.14.2. Product Portfolio

16.1.14.3. Profitability by Market Segments

16.1.14.4. Sales Footprint

16.1.14.5. Strategy Overview

16.1.14.5.1. Marketing Strategy

16.1.15. American Bio Medica Corporation

16.1.15.1. Overview

16.1.15.2. Product Portfolio

16.1.15.3. Profitability by Market Segments

16.1.15.4. Sales Footprint

16.1.15.5. Strategy Overview

16.1.15.5.1. Marketing Strategy

16.1.16. Sciteck, Inc.

16.1.16.1. Overview

16.1.16.2. Product Portfolio

16.1.16.3. Profitability by Market Segments

16.1.16.4. Sales Footprint

16.1.16.5. Strategy Overview

16.1.16.5.1. Marketing Strategy

16.1.17. ACM Global Laboratories

16.1.17.1. Overview

16.1.17.2. Product Portfolio

16.1.17.3. Profitability by Market Segments

16.1.17.4. Sales Footprint

16.1.17.5. Strategy Overview

16.1.17.5.1. Marketing Strategy

16.1.18. CareHealth America

16.1.18.1. Overview

16.1.18.2. Product Portfolio

16.1.18.3. Profitability by Market Segments

16.1.18.4. Sales Footprint

16.1.18.5. Strategy Overview

16.1.18.5.1. Marketing Strategy

16.1.19. Clinical Reference Laboratory, Inc.

16.1.19.1. Overview

16.1.19.2. Product Portfolio

16.1.19.3. Profitability by Market Segments

16.1.19.4. Sales Footprint

16.1.19.5. Strategy Overview

16.1.19.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

Customize Now

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Product and Service, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Product and Service, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Product and Service, 2018 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Product and Service, 2018 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 18: Asia Pacific Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033

Table 19: Asia Pacific Market Value (US$ Million) Forecast by Product and Service, 2018 to 2033

Table 20: Asia Pacific Market Value (US$ Million) Forecast by End User , 2018 to 2033

Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Sample Type, 2018 to 2033

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Product and Service, 2018 to 2033

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User , 2018 to 2033

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End User , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Product and Service, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 17: Global Market Attractiveness by Sample Type, 2023 to 2033

Figure 18: Global Market Attractiveness by Product and Service, 2023 to 2033

Figure 19: Global Market Attractiveness by End User , 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End User , 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Product and Service, 2018 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 37: North America Market Attractiveness by Sample Type, 2023 to 2033

Figure 38: North America Market Attractiveness by Product and Service, 2023 to 2033

Figure 39: North America Market Attractiveness by End User , 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End User , 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Product and Service, 2018 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 57: Latin America Market Attractiveness by Sample Type, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Product and Service, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End User , 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End User , 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Product and Service, 2018 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 77: Europe Market Attractiveness by Sample Type, 2023 to 2033

Figure 78: Europe Market Attractiveness by Product and Service, 2023 to 2033

Figure 79: Europe Market Attractiveness by End User , 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Asia Pacific Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 82: Asia Pacific Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 83: Asia Pacific Market Value (US$ Million) by End User , 2023 to 2033

Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Product and Service, 2018 to 2033

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 97: Asia Pacific Market Attractiveness by Sample Type, 2023 to 2033

Figure 98: Asia Pacific Market Attractiveness by Product and Service, 2023 to 2033

Figure 99: Asia Pacific Market Attractiveness by End User , 2023 to 2033

Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 101: Middle East and Africa Market Value (US$ Million) by Sample Type, 2023 to 2033

Figure 102: Middle East and Africa Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 103: Middle East and Africa Market Value (US$ Million) by End User , 2023 to 2033

Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Sample Type, 2018 to 2033

Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Sample Type, 2023 to 2033

Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Sample Type, 2023 to 2033

Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Product and Service, 2018 to 2033

Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by End User , 2018 to 2033

Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by End User , 2023 to 2033

Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User , 2023 to 2033

Figure 117: Middle East and Africa Market Attractiveness by Sample Type, 2023 to 2033

Figure 118: Middle East and Africa Market Attractiveness by Product and Service, 2023 to 2033

Figure 119: Middle East and Africa Market Attractiveness by End User , 2023 to 2033

Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033